Navigation Links
New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
Date:6/2/2008

se events included fatigue, hand/foot syndrome and skin rash.

The lead investigator for this study is Joan Schiller, MD, professor and chief of the hematology/oncology division at the University of Texas Southwestern and Andrea L. Simmons distinguished chair in cancer research, Dallas, TX. (abstract #8014).

Thyroid Cancer

A Phase 2 Study of Sorafenib in Metastatic Thyroid Carcinoma

Findings from this single-arm Phase 2 study showed that treatment with Nexavar resulted in meaningful anti-tumor activity in the majority of patients with encouraging overall clinical benefit (disease stabilization and partial responses) in patients with advanced thyroid cancer. In the study, Nexavar was well-tolerated; the most common treatment-related adverse events included fatigue, rash, diarrhea, palmer-plantar erythema, musculoskeletal pain and weight loss. Patients enrolled in this study had been diagnosed with metastatic, iodine-refractory, unresectable or locally-advanced thyroid cancer.

The lead investigator for this study is Marcia S. Brose, MD, PhD, assistant professor, director of cancer genetics laboratory, University of Pennsylvania Health System, Philadelphia, PA. (abstract #6026).

Gastrointestinal Stromal Tumors

Activity of Sorafenib in Patients with Imatinib and Sunitinib-Resistant Gastrointestinal Stromal Tumors (GIST): A Phase 2 Trial of the University of Chicago Phase 2 Consortium

Findings from this single-arm Phase 2 study suggest that Nexavar is active and well tolerated in patients with Gleevec or Gleevec and Sutent resistant GIST. The most common treatment-emergent adverse events included hand-foot syndrome, hypertension, rash and diarrhea.

The lead investigator for this study is Lauren Wiebe, MD, fellow, University of Chicago, Chicago, IL. (abstract #10502).

Gastric/GEJ

A Phase 2 Study: Combination of Sorafenib with Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Unres
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
2. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
3. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
9. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
10. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... May 20 The owner and operator of a Houston-area ... program, announced the Departments of Justice and Health and Human Services (HHS). ... William M. ... fraud before U.S. District Judge David Hittner in U.S. District ...
... May 20 Inverness Medical Innovations, Inc. (NYSE: ... charge of their health at home through the merger of rapid ... Citi Global Health Care Conference being held May 26 through ... New York City .  Jon Russell, Vice President, Finance, will attend. ...
Cached Medicine Technology:Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 2Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 3
(Date:9/2/2014)... 02, 2014 Request A Test , a ... a 10% discount on all drug testing in September ... need to use promo code DRUG10 when placing their order. ... blood and hair. Drug testing is typically done in panels ... of the most popular panels include the 5 Panel Urine ...
(Date:9/2/2014)... 02, 2014 Michigan’s health care landscape ... Act and the Healthy Michigan Plan. Throughout these changes, ... a trusted funding resource for under-served individuals. Federal and ... or underinsured women between the ages of 50 and ... percent of the federal poverty level. , ...
(Date:9/2/2014)... ZAMST, a leader in high-performance sports prevention/protective ... baseball star Nolan Arenado . Widely considered ... Arenado will be working with Zamst to continue their ... , Arenado was selected by Colorado in the second ... Arenado was awarded the Gold Glove, putting him among ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Recently, Os-Monitor.com, ... programs, has announced its new collection of employee internet ... is now providing big discounts, up to 10% off, ... company is now selling more than 20 different kinds ... of them are very useful for companies of all ...
(Date:9/2/2014)... San Diego, CA (PRWEB) September 02, 2014 ... kicking coach Anthony Cantele of Cantele Kicking on his role ... a National Camp Series (NCS) Associate according to retired ... a great career at Kansas State University and is one ... Husted. “I had a chance to meet with Anthony at ...
Breaking Medicine News(10 mins):Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:Useful Employee Internet Monitoring Products Now For Sale At Os-Monitor.com 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 3
... , THURSDAY, May 12 (HealthDay News) -- Music ... finding of a study by Northwestern University researchers who compared ... "Lifelong musical training appears to confer advantages in at ... memory and the ability to hear speech in noise," study ...
... inhalers may increase a smoker,s chance of quitting, according to ... . This study is the first to assess ... smoking. The research, which was carried out by ... people who were enrolled in a programme to help them ...
... , WEDNESDAY, May 11 (HealthDay News) -- Autism takes ... underemployment and lost income among mothers, University of Pennsylvania ... for a child with autism, however high, are only ... on families should be considered whenever policymakers fund autism ...
... a patient,s knowledge of family medical history to estimate his ... cancer history are not highly accurate, according to a study ... the National Cancer Institute. Primary care physicians ... screening or referrals to specialists, for instanceon the results. ...
... also known as Lou Gehrig,s disease, may be an exception ... In a retrospective study of over 400 ALS patients, ... mildly obese survived longer than patients who were normal weight, ... the journal Muscle & Nerve and has been published online. ...
... (HealthDay News) -- Among teen boys with an autism ... with a greater degree of bullying behavior than their ... observation specifically reflects upon boys aged 12 to 18, ... intimidation, rumor-mongering and group exclusion that characterize bullying behavior. ...
Cached Medicine News:Health News:Musicians Maintain Memory, Hearing as They Age 2Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 2Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 3Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 4Health News:Patient reports of relatives' cancer history often not accurate 2Health News:Mild obesity appears to improve survival in ALS patients 2Health News:Teen Boys With Autism at Risk of Being Bullied: Study 2
... design includes several innovative features ... coating option for stable fixation ... bone preserving posterior stabilizing design, ... maximize range of motion, simple ...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... Duracon tibial inserts have radiused A/P ... 4-axis machining, maximizing conformity of the ... of the femoral component. The resulting ... Duracon system, and accommodates the knee's ...
Medicine Products: